Trial Profile
Effects of anti-allergic ophthalmic solutions on chemical mediators in tear fluid and on expression of chemical mediator receptors on conjunctival epithelial cells in patients with allergic conjunctivitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Mar 2017
Price :
$35
*
At a glance
- Drugs Epinastine (Primary) ; Olopatadine
- Indications Infectious conjunctivitis
- Focus Therapeutic Use
- 29 Mar 2017 Status changed from not yet recruiting to completed.
- 26 May 2016 New trial record